SDS-PAGE
(SDS PAGE for Secukinumab)
anti-Human Secukinumab Monoclonal Antibody | anti-IL17A antibody
Research Grade Secukinumab
Gene Names
IL17A; IL17; CTLA8; IL-17; IL-17A
Reactivity
Human
Purity
>95%; Protein A or G purified from cell culture supernatant.
Synonyms
Secukinumab, Antibody; Research Grade Secukinumab; AIN457; CTLA-8; Cytotoxic T-lymphocyte-associated antigen 8; IL17; IL-17A; IL17A; CTLA8; IL-17; Interleukin-17A; anti-IL17A antibody
Reactivity
Human
Clonality
Monoclonal
Isotype
IgG1-kappa
Purity/Purification
>95%; Protein A or G purified from cell culture supernatant.
Form/Format
Liquid. PBS buffer, pH7.4
Concentration
1mg/ml (varies by lot)
Host Species
Human
CAS
1229022-83-6
Dry Ice Shipment
Extra charge fee may add to your shipping cost as dry ice is required to ship this product.
Preparation and Storage
Store at +4 degree C short term (1-2 weeks). Store at -20 degree C 12 months. Store at -80 degree C long term.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
SDS-PAGE
(SDS PAGE for Secukinumab)
SDS-PAGE
(SDS PAGE for Secukinumab)
Bioactivity
(Detects Human IL17A in direct ELISAs.)
Bioactivity
(Detects Human IL17A in direct ELISAs.)
Product Categories/Family for anti-IL17A antibody
References
Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial, PMID: 32386593
Safety of secukinumab in the treatment of psoriasis, PMID: 27545070
Secukinumab in plaque psoriasis--results of two phase 3 trials, PMID: 25007392
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis, PMID: 26699169
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial, PMID: 32594522
Safety of secukinumab in the treatment of psoriasis, PMID: 27545070
Secukinumab in plaque psoriasis--results of two phase 3 trials, PMID: 25007392
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis, PMID: 26699169
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial, PMID: 32594522
NCBI and Uniprot Product Information
NCBI GI #
NCBI GeneID
NCBI Accession #
NCBI GenBank Nucleotide #
Molecular Weight
17,504 Da
NCBI Official Full Name
interleukin-17A
NCBI Official Synonym Full Names
interleukin 17A
NCBI Official Symbol
IL17A
NCBI Official Synonym Symbols
IL17; CTLA8; IL-17; IL-17A
NCBI Protein Information
interleukin-17A; CTLA-8; cytotoxic T-lymphocyte-associated antigen 8; cytotoxic T-lymphocyte-associated protein 8; interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8)
UniProt Protein Name
Interleukin-17A
UniProt Gene Name
IL17A
UniProt Synonym Gene Names
CTLA8; IL17; IL-17; IL-17A; CTLA-8
UniProt Entry Name
IL17_HUMAN
Similar Products
Product Notes
The IL17A il17a (Catalog #AAA120110) is an Antibody and is intended for research purposes only. The product is available for immediate purchase. The Research Grade Secukinumab reacts with Human and may cross-react with other species as described in the data sheet. It is sometimes possible for the material contained within the vial of "Secukinumab, Monoclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.